Article Information
History
- September 24, 2020.
Article Versions
- Version 1 (September 14, 2020 - 04:48).
- Version 2 (September 16, 2020 - 12:06).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Melanie P Jensen, MBBS*,1,
- Benjamin Meir Jacobs, MRCP*,1,
- Ruth Dobson, MRCP, PhD1,
- Sara Bandres-Ciga, PhD2,
- Cornelis Blauwendraat, PhD2,
- Anette Schrag, MD, PhD3,
- The International Parkinson’s Disease Genomics Consortium (IPDGC) and
- Alastair J Noyce, MRCP, PhD+,1,3
- 1Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK
- 2Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
- 3Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London, UK
- ↵+Corresponding author Dr Alastair Noyce, Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ Email - a.noyce{at}qmul.ac.uk Telephone - +44 (0) 207 882 5841
↵* equal contribution
Posted September 24, 2020.
